<DOC>
	<DOCNO>NCT00141063</DOCNO>
	<brief_summary>The purpose study compare safety efficacy two dos dexmethylphenidate two dos approve , long-acting , marketed medication ADHD ( MPH ) placebo child age 6-12 diagnosed ADHD .</brief_summary>
	<brief_title>Safety Efficacy Study Dexmethylphenidate Children With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Dexmethylphenidate Hydrochloride</mesh_term>
	<criteria>DSMIV diagnosis ADHD Males female age 612 Inability understand follow instruction Is pregnant Diagnosis tic disorder History seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>ADHD , child</keyword>
</DOC>